Sale!

P3H1 Gene Osteogenesis Imperfecta Type 8 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The P3H1 Gene Osteogenesis Imperfecta Type 8 NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the P3H1 gene responsible for causing Osteogenesis Imperfecta Type 8, a rare inherited bone disorder characterized by bone fragility, skeletal deformities, and connective tissue abnormalities. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to provide precise detection of genetic variants associated with this condition. The test is essential for individuals with unexplained bone fractures, family history of brittle bone disease, or suspected collagen-related disorders. Results provide valuable insights for diagnosis, treatment planning, and genetic counseling. The test is available for $500 USD, offering significant savings from the regular $700 USD price.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

P3H1 Gene Osteogenesis Imperfecta Type 8 NGS Genetic DNA Test

Comprehensive Genetic Analysis for Bone Fragility Disorders

The P3H1 Gene Osteogenesis Imperfecta Type 8 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for individuals affected by brittle bone diseases. This advanced test specifically targets mutations in the P3H1 (Prolyl 3-Hydroxylase 1) gene, which plays a critical role in collagen modification and bone formation. Osteogenesis Imperfecta Type 8 is a rare autosomal recessive condition characterized by severe bone fragility, growth deficiency, and skeletal abnormalities that significantly impact quality of life.

What This Test Measures and Detects

This comprehensive genetic analysis utilizes Next-Generation Sequencing (NGS) technology to examine the complete coding region of the P3H1 gene for pathogenic variants. The test specifically identifies:

  • Point mutations, insertions, and deletions in the P3H1 gene
  • Autosomal recessive inheritance patterns
  • Variants affecting collagen prolyl 3-hydroxylation
  • Genetic markers associated with severe bone fragility
  • Mutations impacting bone mineralization processes

Who Should Consider This Test

This genetic test is recommended for individuals presenting with the following symptoms or risk factors:

  • Unexplained recurrent bone fractures with minimal trauma
  • Family history of Osteogenesis Imperfecta or brittle bone disease
  • Severe skeletal deformities and growth retardation
  • Dentinogenesis imperfecta (discolored, fragile teeth)
  • Blue sclerae (bluish tint to the whites of the eyes)
  • Hearing loss developing in childhood or adolescence
  • Connective tissue abnormalities and joint hypermobility
  • Positive family history of consanguineous relationships

Clinical Benefits of Genetic Testing

Undergoing the P3H1 Gene Osteogenesis Imperfecta Type 8 NGS Genetic DNA Test provides numerous clinical advantages:

  • Accurate Diagnosis: Confirms or rules out Osteogenesis Imperfecta Type 8 with high precision
  • Personalized Treatment: Enables targeted therapeutic interventions and fracture prevention strategies
  • Genetic Counseling: Provides essential information for family planning and recurrence risk assessment
  • Early Intervention: Facilitates proactive management to minimize complications
  • Comprehensive Care Planning: Guides multidisciplinary approach involving orthopedics, genetics, and rehabilitation

Understanding Your Test Results

Our genetic specialists provide comprehensive interpretation of your test results:

  • Positive Result: Indicates the presence of pathogenic mutations in the P3H1 gene, confirming Osteogenesis Imperfecta Type 8 diagnosis
  • Negative Result: Suggests that P3H1 gene mutations are not detected, though other genetic causes should be considered
  • Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact requiring further evaluation
  • Carrier Status: Determines if an individual carries one copy of a mutated gene without showing symptoms

All results are accompanied by detailed genetic counseling to ensure proper understanding and appropriate next steps.

Test Pricing and Details

Test Component Details
Test Name P3H1 Gene Osteogenesis Imperfecta Type 8 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Nationwide Testing Availability

We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many more. Our network ensures accessible genetic testing services for patients throughout the country.

Take Control of Your Genetic Health Today

Don’t let uncertainty about bone fragility disorders affect your quality of life. Our comprehensive P3H1 Gene Osteogenesis Imperfecta Type 8 NGS Genetic DNA Test provides the answers you need for informed medical decisions. Our experienced genetic counselors are available to discuss your concerns and guide you through the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward accurate diagnosis and personalized care.

Early genetic testing can make a significant difference in managing Osteogenesis Imperfecta and improving long-term outcomes. Trust our expertise in genetic diagnostics to provide the clarity and guidance you deserve.